| Literature DB >> 25879998 |
Martijn Beudel1,2, Simon Little1, Alek Pogosyan1, Keyoumars Ashkan3, Thomas Foltynie4, Patricia Limousin4, Ludvic Zrinzo4, Marwan Hariz4, Marko Bogdanovic1, Binith Cheeran1, Alexander L Green1, Tipu Aziz1, Wesley Thevathasan1,5,6, Peter Brown1.
Abstract
OBJECTIVES: Rest tremor is a cardinal symptom of Parkinson's disease (PD), and is readily suppressed by deep brain stimulation (DBS) of the subthalamic nucleus (STN). The therapeutic effect of the latter on bradykinesia and rigidity has been associated with the suppression of exaggerated beta (13-30 Hz) band synchronization in the vicinity of the stimulating electrode, but there is no correlation between beta suppression and tremor amplitude. In the present study, we investigate whether tremor suppression is related to suppression of activities at other frequencies.Entities:
Keywords: Deep brain stimulation; Parkinson's disease; mechanisms of action; subthalamic nucleus; tremor
Mesh:
Year: 2015 PMID: 25879998 PMCID: PMC4829100 DOI: 10.1111/ner.12297
Source DB: PubMed Journal: Neuromodulation ISSN: 1094-7159
Clinical and Stimulation Details of Patients
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | Patient 9 | Patient 10 | Patient 11 | Mean + SEM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age (years) | 59 | 59 | 48 | 54 | 62 | 78 | 66 | 61 | 51 | 52 | 70 | 60 ± 2.7 |
| Disease duration (years) | 14 | 16 | 20 | 9 | 9 | 5 | 6 | 13 | 11 | 8 | 13 | 11.2 ± 1.3 |
| UPDRS off‐drugs | 59 | 42 | 56 | 19 | 46 | 29 | 32 | 33 | 38 | 40 | 45 | 39.9 ± 3.5 |
| UPDRS on‐drugs | 19 | 10 | 33 | 6 | 16 | 26 | 4 | 12 | 13 | 11 | 35 | 16.8 ± 3.1 |
| Surgery location | OX | OX | OX | OX | OX | UCL | OX | UCL | UCL | UCL | KC | — |
| Initial symptom | Tremor | Tremor | Rigidity | Tremor | Rigidity | Tremor | Tremor | Tremor | Tremor | Tremor | Tremor | — |
| Primary DBS indication | Tremor | Tremor | Off‐periods | Off‐periods | Off‐periods | Tremor | Off‐periods | Tremor | Off‐periods | Off‐periods | Tremor | — |
| Preoperative drugs | Levodopa, Pramipexole | Levodopa, Amantadine, Cabergoline | Levodopa, Ropinirole | Levodopa, Entacapone, Pramipexole, Selegeline | Levodopa, Tolcapone | Levodopa, Entacapone | Levodopa, Pramipexole | Levodopa, Ropinirole, Rasagiline, Amantadine | Levodopa, Entacapone, Rotigotine | Levodopa, Rotigotine | Levodopa, Rotigotine | — |
| LED (mg/day) | 1080 | 1050 | 700 | 1700 | 800 | 1200 | 1315 | 1715 | 1573 | 620 | 1140 | 1172 ± 114 |
| Recorded hemisphere(s) | L/R | L | R | L/R | L/R | L | L | R | L | L/R | R | — |
| 50% tremor suppression voltage | 1.5/0.5 | 1 | 3.0 | 1/2.5 | 3/3.5 | 3.5 | 3.5 | 2.5 | 2.5 | 1.5 | 2 | 2.3 ± 0.3 |
Fifty percent tremor suppression voltages indicate the stimulation voltage at which tremor was reduced to 50% of its original amplitude.
DBS, deep brain stimulation; KC, King's College; L, left; LED, levodopa equivalent dose; OX, Oxford; R, right; SEM, standard error of the mean; UCL, University College London; UPDRS, Unified Parkinson's Disease Rating Scale Part III (motor).
Figure 1Example recording (case 3). Time‐evolving STN LFP spectrum and contralateral upper limb tremor are shown, together with the timings of incremental changes in stimulation. No stimulation is applied at the beginning and end of the recordings. The LFP is shown as a spectrogram, with cold colors representing lowest power (so blue, white, yellow, and then red reflect increasing power). To the right of time‐evolving spectrogram is a time‐averaged LFP power spectrum in red demonstrating discrete peaks at twice tremor frequency (10 Hz) and in the beta band (peaking at 26 Hz), but no such discrete peak in the low gamma (31–45 Hz) band. Onset and offset of tremor suppression is delayed for a few seconds after corresponding voltage changes. In contrast, return of gamma power to baseline levels is very rapid upon cessation of stimulation. Below the time‐evolving spectrogram (bottom trace) is the control chart of the 31–45 Hz LFP power estimated in nonoverlapping 4 sec blocks. Red horizontal lines either side of the power trace in black are the control limits of the whole recording. The blue blocks represent periods of constant 31–45 Hz power identified by change‐point analysis (p < 0.01) 23. The vertical extent of the blue blocks denotes the 99% confidence limits centered on the mean of each stable period. Short black horizontal lines at the top are the 99% confidence limits of the changes in gamma power (10,000 bootstraps). Change‐point analysis independently confirms that gamma power was reduced around the time of increasing stimulation voltage to 2.5 V and 3.5 V. Gamma power then rebounded when stimulation was stopped. Stimulation was delivered at 130 Hz with 90 μsec pulse width and applied at contact 1. The LFP was recorded from contacts 02 on the right. The tremor was recorded with an accelerometer taped to the dorsum of the left (contralateral) hand. LFP, local field potential; STN, subthalamic nucleus.
Figure 2Average amplitudes of (a) tremor and (b) 31–45 Hz activities over the different stimulation ranges. Data are normalized to the no‐stimulation condition (left column). Vertical gray bars depict mean values and the black stripes the standard error of this mean. a.u., arbitrary units; no‐stim, no‐stimulation; ns, nonsignificant. *p < 0.05; ***p < 0.005; ****p < 0.001.
Figure 3Average correlations of 4–12, 13–30, and 31–45 Hz band LFP and tremor amplitudes. Vertical bars depict the mean Spearman's rho of the correlation analyses between normalized tremor amplitude and normalized 4–12, 13–30, and 31–45 Hz power. The black stripes indicate the standard error of the mean. ns, nonsignificant. **p < 0.01. LFP, local field potential.